Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies
Background: Although immunotherapy with checkpoint inhibitors is changing the face of lung adenocarcinoma (LUAD) treatments, only limited patients could benefit from it. Therefore, we aimed to develop an immune-relevant-gene-based signature to predict LUAD patients' prognosis and to characteriz...
Main Authors: | Liang Xue, Guoshu Bi, Cheng Zhan, Yi Zhang, Yunfeng Yuan, Hong Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00835/full |
Similar Items
-
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01) -
Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01) -
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
by: Xiaodong Yang, et al.
Published: (2019-07-01) -
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
by: Pancheng Wu, et al.
Published: (2020-10-01) -
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
by: Jixin Wang, et al.
Published: (2021-02-01)